- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06034392
Repositorio y estudio cardíaco de la aplicación CHAMP (CHAMP)
Estudio cardíaco de la aplicación CHAMP: evaluación de funciones de software para la monitorización asincrónica de niños con cardiopatías congénitas complejas en el hogar y en el repositorio de datos
This is a multi-site research study with an optional research repository that will consist of clinically derived data and photographic or video images of patients in the home setting with complex health conditions to evaluate the safety and efficacy of the CHAMP® software platform, with data and photographic or video images input and/or uploaded by the parent or other legally authorized representative (LAR) of patients with complex congenital heart disease as a target population.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Study objectives
- To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated
- To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
- To evaluate the use of the CHAMP App for clinical purposes, including user satisfaction with the data entry, parental self-management, and transmission capabilities.
- To evaluate the real-world performance analytics (RWPA) of the CHAMP software platform for transfer of parent-entered data for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
Endpoints
- To demonstrate that parents and caregivers for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated can accurately identify and transmit to healthcare providers specific health-related data including intake of food, fluids and mediations; output, including urination, defecation, and vomiting; weight; vital signs including oxygen saturation as measured by pulse oximetry; heart rate as measured either by a heart rate monitor or manually by the parent or caregiver; and temperature, measured by a reliable thermometer; and the value and reliability of videos provided by parents and caregivers regarding behavior of pediatric study participants for use in evaluating participant's health status.
- To demonstrate that data obtained through the use of devices such as pulse oximeters, as entered into the app by parents and caregivers, provide valuable information regarding the health status of children with Complex Diagnoses in a home setting.
- To demonstrate characteristics of CHAMP through real world health analytics (RWHA), user experience analytics (UX), and product performance analytics (PPA).
The study duration is open-ended for safety, effectiveness, and performance of the CHAMP app. Unless consent is withdrawn, data will be kept and used for data analysis and, if consented to the research repository for multi-site research purposes indefinitely. At age 18, previously pediatric patients may be approached for reconsent.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
District of Columbia
-
Washington D.C., District of Columbia, Estados Unidos, 20010
- Children's National Hospital
-
-
Florida
-
Miami, Florida, Estados Unidos, 33155
- Nicklaus Variety Children's Hospital
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70118
- Children's Hospital New Orleans
-
-
Missouri
-
Kansas City, Missouri, Estados Unidos, 64108
- Children's Mercy Hospital
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45219
- Cincinnati Children's Hospital Medical Center
-
Columbus, Ohio, Estados Unidos, 43205
- Nationwide Children's Hospital
-
-
Texas
-
Forth Worth, Texas, Estados Unidos, 76104
- Cook's Children's
-
Houston, Texas, Estados Unidos, 77030
- Children's Memorial Hermann Hospital
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84108
- Primary Children's Hospital/University of Utah
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Pediatric patients with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated in the home setting through a multi-regional approach.
Parents who utilize their CHAMP App and the healthcare team that log-in are also part of the CHAMP App study.
Descripción
Inclusion Criteria:
- Age 0-17 years with a parent/Legally authorized representative
- Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate.
- Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring.
- Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City.
Adult participants
- Parents/Legally authorized representatives of pediatric subject.
- Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.
Exclusion Criteria:
- Inability to be discharged to care in the home setting.
- Those not meeting the above inclusion criteria.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: OTHER
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Human factors/usability engineering: Login failures
Periodo de tiempo: Over a 3 month period
|
Rate of attempts of log-in failures |
Over a 3 month period
|
|
Human factors/usability engineering: Imprecision
Periodo de tiempo: Over a 3 month period
|
Rate of data values reported with imprecision |
Over a 3 month period
|
|
Clinical Safety: Anticipated adverse events
Periodo de tiempo: Over a 3 month period
|
Anticipated Adverse event rates |
Over a 3 month period
|
|
Clinical Safety: Event resolution- anticipated
Periodo de tiempo: Time in days, reported over the last 3 months
|
Time to resolve anticipated adverse events |
Time in days, reported over the last 3 months
|
|
Clinical Safety: Unanticipated Adverse events
Periodo de tiempo: Time in days, reported over the last 3 months
|
Unanticipated adverse event rates |
Time in days, reported over the last 3 months
|
|
Clinical Safety: Event resolution- unanticipated
Periodo de tiempo: Time in days, reported over the last 3 months
|
Time to resolve unanticipated adverse events |
Time in days, reported over the last 3 months
|
|
Health Benefits: Adherence
Periodo de tiempo: Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
|
Rate of adherence to daily data entry |
Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
|
|
User Satisfaction: Complaints
Periodo de tiempo: Over a 3 month period
|
Complaint rates via the healthcare team web portal |
Over a 3 month period
|
|
User Satisfaction CHAMP Video
Periodo de tiempo: through study completion, an average of 9 months
|
Feedback from healthcare team will be received via treatment endpoint survey questions. Likert scale questions 1-strongly disagree to 5 strongly agree (Using CHAMP videos for the interstage monitoring of this patient improved clinical decisions for the home monitoring team). Available to put in comments. |
through study completion, an average of 9 months
|
|
User Satisfaction: Communication
Periodo de tiempo: through study completion, an average of 9 months
|
Feedback from healthcare team will be received via treatment endpoint survey questions Likert scale questions 1-strongly disagree to 5 strongly agree ( Using CHAMP for the interstage monitoring of this patient improved communication with the parents at home.) Available to put in comments. |
through study completion, an average of 9 months
|
|
User Engagement
Periodo de tiempo: Over a 3 month perriod
|
Total number of registered users (Active, treatment endpoint reached) and data totals per parent entered measure. De-identified Demographics and age areas utilization -Utilization across the number of pediatric sites, healthcare teams |
Over a 3 month perriod
|
|
CHAMP app performance: Downtime
Periodo de tiempo: Over a 3 month period
|
Product Performance Analytics measured through Any system downtime |
Over a 3 month period
|
|
CHAMP app performance: Cybersecurity
Periodo de tiempo: Over a 3 month period
|
Product Performance Analytics measured through Any reported breaches |
Over a 3 month period
|
|
CHAMP app performance
Periodo de tiempo: Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required
|
Product Performance Analytics measured through --Bug/defect rate or Version failure rates |
Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lori Erickson, PhD, Director, Remote Health Solutions Children's Mercy
Publicaciones y enlaces útiles
Publicaciones Generales
- Shirali G, Erickson L, Apperson J, Goggin K, Williams D, Reid K, Bradley-Ewing A, Tucker D, Bingler M, Spertus J, Rabbitt L, Stroup R. Harnessing Teams and Technology to Improve Outcomes in Infants With Single Ventricle. Circ Cardiovasc Qual Outcomes. 2016 May;9(3):303-11. doi: 10.1161/CIRCOUTCOMES.115.002452. Epub 2016 May 10.
- Bingler M, Erickson LA, Reid KJ, Lee B, O'Brien J, Apperson J, Goggin K, Shirali G. Interstage Outcomes in Infants With Single Ventricle Heart Disease Comparing Home Monitoring Technology to Three-Ring Binder Documentation: A Randomized Crossover Study. World J Pediatr Congenit Heart Surg. 2018 May;9(3):305-314. doi: 10.1177/2150135118762401.
- Aly DM, Erickson LA, Hancock H, Apperson JW, Gaddis M, Shirali G, Goudar S. Ability of Video Telemetry to Predict Unplanned Hospital Admissions for Single Ventricle Infants. J Am Heart Assoc. 2021 Aug 17;10(16):e020851. doi: 10.1161/JAHA.121.020851. Epub 2021 Aug 7.
- Erickson LA, Emerson A, Russell CL. Parental mobile health adherence to symptom home monitoring for infants with congenital heart disease during the single ventricle interstage period: A concept analysis. J Spec Pediatr Nurs. 2020 Oct;25(4):e12303. doi: 10.1111/jspn.12303. Epub 2020 Jul 14.
- Patel PS, Shah SK, Feldman K, Hancock HS, Moehlmann ML, Ricketts A, Files MD, McFarland C, Erickson L, Romans RA. Associations of Home Monitoring Data to Interventional Catheterization for Infants with Recurrent Coarctation of the Aorta and Hypoplastic Left Heart Syndrome. Pediatr Cardiol. 2023 Oct;44(7):1462-1470. doi: 10.1007/s00246-023-03224-8. Epub 2023 Jul 8.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 15030113CMH
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .